Related Experiment Videos
Transforming growth factor beta 1 regulation of c-myc expression, pRB phosphorylation, and cell cycle progression in
K Münger1, J A Pietenpol, M R Pittelkow
1Laboratory of Tumor Virus Biology, National Cancer Institute, Bethesda, Maryland 20892.
Abstract:
Transforming growth factor beta 1 (TGF-beta 1) is a potent inhibitor of cellular proliferation in a variety of cell types, including skin keratinocytes. TGF-beta 1 suppression of c-myc transcription has been implicated in the mechanism of TGF-beta 1 inhibition of keratinocytes, and evidence suggests that the protein product of the retinoblastoma gene (pRB) is a necessary component in this pathway. Following growth factor stimulation of quiescent keratinocytes, TGF-beta 1 can inhibit cell cycle progression into S phase at any point prior to the G1-S transition but does not inhibit progression through the S phase of the cell cycle. Since pRB is hypophosphorylated during G1 and hyperphosphorylated during S and G2, the G1-S-specific phosphorylation of pRB becomes an attractive target for the growth-inhibitory activities of TGF-beta 1. However, in TGF-beta 1-treated primary human keratinocytes and in a series of human papilloma virus and SV40 immortalized human keratinocyte cell lines, the phosphorylation status of pRB strictly correlated with cell growth. No evidence was found for a direct effect of TGF-beta 1 on the phosphorylation state of pRB in these cells. It was further demonstrated that synthesis of c-myc protein can be rapidly inhibited by TGF-beta 1 addition throughout G1 and S phases, indicating that the phosphorylation state of pRB, at least as it varies during the cell cycle, does not alter the ability of TGF-beta 1 to suppress c-myc expression.(ABSTRACT TRUNCATED AT 250 WORDS)
Insights
Transforming growth factor beta 1 (TGF-beta 1) inhibits keratinocyte proliferation by suppressing c-myc. This study found TGF-beta 1
Area of Science:
- Cell Biology
- Molecular Biology
- Dermatology
Background:
- Transforming growth factor beta 1 (TGF-beta 1) inhibits keratinocyte proliferation.
- TGF-beta 1's mechanism involves c-myc suppression and potentially the retinoblastoma protein (pRB).
- TGF-beta 1 inhibits cell cycle progression before the G1-S transition.
Purpose of the Study:
- Investigate the role of pRB phosphorylation in TGF-beta 1-mediated growth inhibition.
- Determine if TGF-beta 1 directly affects pRB phosphorylation status.
- Clarify the relationship between pRB phosphorylation and c-myc suppression by TGF-beta 1.
Main Methods:
- Treatment of primary human keratinocytes and immortalized cell lines with TGF-beta 1.
- Analysis of pRB phosphorylation status during the cell cycle.
- Assessment of c-myc protein synthesis following TGF-beta 1 treatment.
Main Results:
- pRB phosphorylation status correlated with cell growth in TGF-beta 1-treated cells.
- No direct effect of TGF-beta 1 on pRB phosphorylation was observed.
- TGF-beta 1 rapidly inhibited c-myc synthesis throughout G1 and S phases.
Conclusions:
- TGF-beta 1's growth inhibition of keratinocytes is independent of pRB phosphorylation status.
- The suppression of c-myc by TGF-beta 1 is not modulated by cell cycle-dependent pRB phosphorylation.